Virulent variants emerging in mice infected with the apathogenic prototype strain of the parvovirus minute virus of mice exhibit a capsid with low avidity for a primary receptor.
about
Parvovirus glycan interactionsEngineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer.Host-selected amino acid changes at the sialic acid binding pocket of the parvovirus capsid modulate cell binding affinity and determine virulence.The Mammalian Cell Cycle Regulates Parvovirus Nuclear Capsid Assembly.Protruding domain of capsid protein is necessary and sufficient to determine murine norovirus replication and pathogenesis in vivoEvolution to pathogenicity of the parvovirus minute virus of mice in immunodeficient mice involves genetic heterogeneity at the capsid domain that determines tropism.Late Maturation Steps Preceding Selective Nuclear Export and Egress of Progeny Parvovirus.A slender tract of glycine residues is required for translocation of the VP2 protein N-terminal domain through the parvovirus MVM capsid channel to initiate infection.Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsid.Escape of tick-borne flavivirus from 2' -C-methylated nucleoside antivirals is mediated by a single conservative mutation in NS5 that has a dramatic effect on viral fitness.Low pH-dependent endosomal processing of the incoming parvovirus minute virus of mice virion leads to externalization of the VP1 N-terminal sequence (N-VP1), N-VP2 cleavage, and uncoating of the full-length genome.Quantitatively probing propensity for structural transitions in engineered virus nanoparticles by single-molecule mechanical analysis.Minute virus of mice, a parvovirus, in complex with the Fab fragment of a neutralizing monoclonal antibody.Identification of the sialic acid structures recognized by minute virus of mice and the role of binding affinity in virulence adaptation.Atomic Resolution Structure of the Oncolytic Parvovirus LuIII by Electron Microscopy and 3D Image Reconstruction.Protoparvovirus Cell Entry.
P2860
Q26858992-9783E17A-D0B8-4EE4-8FC6-D3D668DE7094Q33833473-EC983CFD-995A-49BA-BD3D-BECCA0BDD1B7Q34302122-02092CBD-8F4A-4B4D-AECC-A73E73410BCAQ35739162-E552FE51-FF08-4B72-BB5D-3E9015625E01Q35826359-74E5EC4C-36CE-43D5-8E8D-53C81E1EE40CQ36424135-583FEC3C-DCAB-4B6B-A342-B3FD2025324AQ38783711-5BCDBA68-37C6-4A9D-86B9-E9EAABDA7521Q39122157-6D9C4166-6904-40D1-9CFE-5351C91E6AACQ39410097-EBC65267-A5DF-416B-A411-6FAB52C264E4Q40080931-FD835C49-E6C9-461C-A9B3-766C2DE0E9AFQ40335931-265E8F00-8065-431F-9F4E-F5CB3436E1CCQ41447173-A5590236-7521-423B-8462-4DB19AF4E930Q41624316-54B1390B-650E-4BBF-AB27-369E705774D8Q45414844-C7E0E69F-755D-4DCC-8860-7ED355AFEFD8Q46210737-4F4E50F9-0FC8-4BE1-BF3E-6320BED24FE0Q46274294-1E354876-D40C-4D5B-BBAC-E5A344F9D694
P2860
Virulent variants emerging in mice infected with the apathogenic prototype strain of the parvovirus minute virus of mice exhibit a capsid with low avidity for a primary receptor.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Virulent variants emerging in ...... vidity for a primary receptor.
@ast
Virulent variants emerging in ...... vidity for a primary receptor.
@en
type
label
Virulent variants emerging in ...... vidity for a primary receptor.
@ast
Virulent variants emerging in ...... vidity for a primary receptor.
@en
prefLabel
Virulent variants emerging in ...... vidity for a primary receptor.
@ast
Virulent variants emerging in ...... vidity for a primary receptor.
@en
P2093
P2860
P1433
P1476
Virulent variants emerging in ...... vidity for a primary receptor.
@en
P2093
Alberto López-Bueno
José M Almendral
Mari-Paz Rubio
P2860
P304
11280-11290
P356
10.1128/JVI.79.17.11280-11290.2005
P407
P577
2005-09-01T00:00:00Z